Antidepressant informed consent is the question at the center of this conversation with Kim Witczak. After her husband Woody died five weeks after beginning Zoloft prescribed off-label for insomnia, Kim became an advocate for drug safety, transparency, and public accountability. She and Mike examine the patient’s role in a system shaped by pharmaceutical marketing, warning labels, social media, and FDA approval decisions.

A note before you listen: this conversation covers antidepressants, pharmaceutical marketing, drug safety, and the subject of suicide. It is shared for educational purposes only and is not medical advice; it is not a recommendation to start, stop, or change any medication (make medication decisions with your prescribing clinician). If you are struggling or in crisis, support is available 24/7: in the US, call or text 988 ( ...